The purpose of this legislation, known as the Nitazene Control Act, is to permanently classify a group of synthetic opioids called nitazenes as Schedule I substances under the Controlled Substances Act. This classification aims to address the growing concerns about their potency and potential for abuse, as well as their presence in the illegal drug market, which has contributed to an increase in overdose deaths. Key provisions of the law include the formal listing of nitazenes and their analogs as Schedule I substances.